Malta vs Norway: Immunization, Hib3
Malta
97.0%
in 2024
Norway
97.0%
in 2024
Malta rank
29th
Norway rank
29th
Immunization, Hib3 over time
- Malta
- Norway
How they compare
Malta currently reports 97.0% against 97.0% in Norway, a difference of 0.0%.
The two have swapped places 2 times across 29 shared years of data; in 1996 it was Norway ahead.
Malta ranks 29th and Norway ranks 29th of 191 countries.
Across the 4 decades both report, Malta averaged higher in 2 and Norway in 2.
Head to head by decade
| Decade | Malta | Norway | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 70.5% | 95.5% | 25.0% | Norway |
| 2000s | 81.1% | 94.1% | 13.0% | Norway |
| 2010s | 95.6% | 95.3% | 0.3% | Malta |
| 2020s | 98.0% | 96.8% | 1.2% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Malta or Norway?
- Malta, at 97.0% against 97.0% in Norway as of 2024.
- What is the difference in immunization, hib3 between Malta and Norway?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Norway?
- 29 years are reported by both, from 1996 to 2024.
- How do Malta and Norway rank globally for immunization, hib3?
- Malta ranks 29th and Norway ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.